EUR 9.1
(0.0%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | -3.8 Million EUR | -127.34% |
2022 | 13.9 Million EUR | 414.81% |
2021 | 1.6 Million EUR | 35.0% |
2020 | 2 Million EUR | 137.04% |
2019 | -5.4 Million EUR | 78.4% |
2018 | -25 Million EUR | 72.04% |
2017 | -39.9 Million EUR | -14.62% |
2016 | -41.5 Million EUR | -182.61% |
2015 | -27.6 Million EUR | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q1 | -650.00 EUR | 21.21% |
2024 Q2 | -650.00 EUR | 0.0% |
2023 Q2 | -1050.00 EUR | 0.0% |
2023 Q1 | -1050.00 EUR | 48.15% |
2023 Q4 | -825.00 EUR | -3.13% |
2023 Q3 | -800.00 EUR | 23.81% |
2023 FY | - EUR | -127.34% |
2022 Q1 | 500.00 EUR | 0.0% |
2022 Q2 | 500.00 EUR | 0.0% |
2022 Q3 | -2000.00 EUR | -500.0% |
2022 Q4 | -2025.00 EUR | -1.25% |
2022 FY | - EUR | 414.81% |
2021 Q2 | 250.00 EUR | 0.0% |
2021 FY | - EUR | 35.0% |
2021 Q1 | 250.00 EUR | -16.67% |
2020 Q1 | 150.00 EUR | 104.11% |
2020 FY | - EUR | 137.04% |
2020 Q4 | 300.00 EUR | 120.0% |
2020 Q2 | 150.00 EUR | 0.0% |
2020 Q3 | -1500.00 EUR | -1100.0% |
2019 Q1 | -1100.00 EUR | 80.0% |
2019 Q4 | -3650.00 EUR | 0.0% |
2019 Q2 | -1100.00 EUR | 0.0% |
2019 FY | - EUR | 78.4% |
2019 Q3 | -3650.00 EUR | -231.82% |
2018 Q2 | -3150.00 EUR | 0.0% |
2018 Q3 | -5500.00 EUR | -74.6% |
2018 Q4 | -5500.00 EUR | 0.0% |
2018 FY | - EUR | 72.04% |
2018 Q1 | -3150.00 EUR | 67.69% |
2017 FY | - EUR | -14.62% |
2017 Q4 | -9750.00 EUR | 0.0% |
2017 Q3 | -9750.00 EUR | 4.41% |
2017 Q2 | -10.2 Thousand EUR | 0.0% |
2017 Q1 | -10.2 Thousand EUR | 19.69% |
2016 Q1 | -8050.00 EUR | 99.96% |
2016 FY | - EUR | -182.61% |
2016 Q4 | -12.7 Thousand EUR | 0.0% |
2016 Q3 | -12.7 Thousand EUR | -57.76% |
2016 Q2 | -8050.00 EUR | 0.0% |
2015 FY | - EUR | 0.0% |
2015 Q2 | -10.42 Million EUR | 0.0% |
2015 Q1 | -10.42 Million EUR | 0.0% |
2015 Q4 | -19.05 Million EUR | -82.73% |
2015 Q3 | -10.42 Million EUR | 0.0% |
2014 Q4 | -10.42 Million EUR | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
AB Science S.A. | -9.28 Million EUR | 59.056% |
Boiron SA | 80.67 Million EUR | 104.71% |
Ipsen S.A. | 1.14 Billion EUR | 100.332% |
Vetoquinol SA | 104.58 Million EUR | 103.634% |